Search by Drug Name or NDC

    NDC 43063-0755-30 Hydrochlorothiazide 25 mg/1 Details

    Hydrochlorothiazide 25 mg/1

    Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 43063-0755
    Product ID 43063-755_065931a9-4740-0e99-e063-6394a90a9423
    Associated GPIs 37600040000305
    GCN Sequence Number 008182
    GCN Sequence Number Description hydrochlorothiazide TABLET 25 MG ORAL
    HIC3 R1F
    HIC3 Description THIAZIDE AND RELATED DIURETICS
    GCN 34824
    HICL Sequence Number 003649
    HICL Sequence Number Description HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name HYDROCHLOROTHIAZIDE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA040412
    Listing Certified Through 2024-12-31

    Package

    NDC 43063-0755-30 (43063075530)

    NDC Package Code 43063-755-30
    Billing NDC 43063075530
    Package 30 TABLET in 1 BOTTLE, PLASTIC (43063-755-30)
    Marketing Start Date 2017-06-15
    NDC Exclude Flag N
    Pricing Information N/A